logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Natera Acquires Reproductive Health Assets from Invitae

Jan 22, 2024•almost 2 years ago

Acquiring Company

Natera

Acquired Company

Invitae

AustinSan FranciscoBiotechnologyBiotechnology

Description

Natera, Inc. has acquired certain assets related to non-invasive prenatal screening and carrier screening business from Invitae, a leading medical genetics company. This strategic acquisition is aligned with Natera’s commitment to providing excellent service and aims to support additional patients and providers.

Company Information

Company

Natera

Location

Austin, Texas, United States

About

Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives. Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment. Through a cfDNA technology platform approach, we've pioneered noninvasive testing in unlimited applications—each with their own potential to revolutionize care for patients.

Related People

Sign in to view contact details

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed